Selvita S.A. (WSE:SLV)
22.10
+0.10 (0.45%)
Sep 25, 2026, 11:15 AM CET
Selvita Revenue
Selvita had revenue of 84.65M PLN in the quarter ending June 30, 2026, a decrease of -10.92%. This brings the company's revenue in the last twelve months to 349.00M, down -6.66% year-over-year. In the year 2025, Selvita had annual revenue of 370.57M with 7.17% growth.
Revenue (ttm)
349.00M
Revenue Growth
-6.66%
P/S Ratio
1.16
Revenue / Employee
388.21K
Employees
899
Market Cap
403.82M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 370.57M | 24.80M | 7.17% |
| Dec 31, 2024 | 345.76M | -6.09M | -1.73% |
| Dec 31, 2023 | 351.85M | -12.70M | -3.48% |
| Dec 31, 2022 | 364.55M | 48.83M | 15.47% |
| Dec 31, 2021 | 315.73M | 173.80M | 122.46% |
| Dec 31, 2020 | 141.93M | -104.34B | -99.86% |
| Dec 31, 2019 | 104.48B | 21.42B | 25.78% |
| Dec 31, 2018 | 83.06B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| NEUCA | 14.14B |
| Diagnostyka | 2.58B |
| Synektik Spólka Akcyjna | 932.97M |
| Centrum Medyczne ENEL-MED | 885.29M |
| Voxel | 640.61M |
| Mercator Medical | 572.42M |
| BIOTON | 257.23M |
| Ryvu Therapeutics | 83.94M |
Selvita News
- 7 days ago - Selvita Quarterly report: Q2 2026 - Filings
- 4 months ago - Selvita Quarterly report: Q1 2026 - Filings
- 4 months ago - Selvita Slides: Q1 2026 - Filings
- 5 months ago - Selvita Annual report: Q4 2025 - Filings
- 5 months ago - Selvita Slides: Q4 2025 - Filings
- 10 months ago - Selvita Quarterly report: Q3 2025 - Filings
- 10 months ago - Selvita Slides: Q3 2025 - Filings